Organization: Canaccord Capital Corp

CardioMetabolics receives $4.1 million in financing

CardioMetabolics Inc has secured $4.1 million in a private equity financing to advance its work on drug candidates for cardiovascular disease and related metabolic conditions. Canaccord Capital Corp led the financing of the Edmonton-based, privately held firm. CardioMetabolics’ initial target for its lead drug candidate is to improve outcomes and recovery times for patients who…

Westport Innovations raises $12.6 million

Westport Innovations Inc has concluded a bought financing deal for gross proceeds of $12.6 million. The financing was provided by a syndicate led by Canaccord Capital Corp and includes National Bank Financial Inc, CIBC World Markets, Raymond James Ltd and TD Securities Ltd. The proceeds will be used by the Vancouver-based developer and manufacturer of…

YM Biosciences concludes $23-million financing

YM Biosciences Inc has concluded a bought financing deal for gross proceeds of $23 million. The Mississauga ON-based firm will receive the financing from a syndicate led by Dundee Securities Corp and including Canaccord Capital Corp, Dlouhy Merchant Group and Haywood Securities. The proceeds will be used primarily to finance pivotal Phase III clinical trials…

Westport raises $16.6 million to fund R&D

Westport Innovations Inc has added $16.6 million to its R&D war chest via a bought deal financing agreement with several investment brokers led by Raymond James Ltd. The syndicate also includes National Bank Financial Inc, TD Securities Inc, Canaccord Capital Corp and Sprott Securities. The investors also have the option on more shares – valued…